Clinical Trials Browser

Phase 2 × penpulimab × CNS × Clear all

NCT05885399 2023-06-02

The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment

Phase 2 Unknown

Neoplasm Metastasis, Paraganglioma, Extra-Adrenal, Pheochromocytoma